66
Participants
Start Date
July 20, 2021
Primary Completion Date
May 2, 2023
Study Completion Date
May 2, 2023
Arm I (Propofol)
Propofol group will be inducted and maintained total intravenous anesthesia with propofol 2% and remifentanil under Shinider and Minto target controlled infusion (TCI) model, respevtively.
Arm II (Remimazolam)
Remimazolam group started total intravenous anesthesia with remiamazolam at 6 mg/kg/h at the time of anesthesia induction, and maintained at 0.5-1.5 mg/kg/h.
GangnamSeverance Hospital, Seoul
Gangnam Severance Hospital
OTHER